Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 5,500 shares at $83.92 ($463K) on 2026-05-06, disclosed to the SEC on 2026-05-08.
Scheduled sale ($463k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.92 | 3,700 | $311K | 67.1% |
| 2 | $84.60 | 1,800 | $152K | 32.9% |
| Total | $84.14 avg | 5,500 | $463K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |